Losartan as a Steroid-Sparing Adjunct in a Patient With Features of Refractory Camurati-Engelmann Disease

OBJECTIVE: The treatment of Camurati-Engelmann disease (CED) involves the use of glucocorticoids, analgesics, and bisphosphonates; experience with the use of losartan is limited. Our objective was to describe the case of a patient diagnosed with CED whose symptoms remained refractory while on steroi...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwal, Khushboo, Rajan, Remya, Paul, Jinson, Cherian, Kripa Elizabeth, Kapoor, Nitin, Paul, Thomas V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association of Clinical Endocrinology 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984203/
https://www.ncbi.nlm.nih.gov/pubmed/35415233
http://dx.doi.org/10.1016/j.aace.2021.08.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984203/
https://www.ncbi.nlm.nih.gov/pubmed/35415233
http://dx.doi.org/10.1016/j.aace.2021.08.002

Ejemplares similares